Literature DB >> 6703544

Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients.

S E Straus, M Seidlin, H Takiff, D Jacobs, D Bowen, H A Smith.   

Abstract

Thirty-two episodes of herpes simplex virus infection in four immunodeficient patients with frequent recurrences were successfully treated with oral acyclovir, one capsule five times a day for 5 days. In 23 of these episodes, the treatments were extended for 1 to 6 months using two to five capsules a day with the aim of suppressing expected recurrences. In these patients, who routinely had more than one recurrence per month before treatment, there were only six outbreaks during more than 60 patient-months of suppressive therapy. Infection always recurred after treatments were completed, but the time to recurrence was shorter after treatments with two acyclovir capsules per day than after treatments with five capsules per day (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703544     DOI: 10.7326/0003-4819-100-4-522

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

Review 1.  Drug treatment of HIV-related opportunistic infections.

Authors:  M E Klepser; T B Klepser
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Chemotherapy of herpesvirus infections: present successes and future hopes.

Authors:  S Crowe; J Mills
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

Review 3.  Chemotherapy for herpes simplex virus infections.

Authors:  K S Erlich; J Mills
Journal:  West J Med       Date:  1985-11

Review 4.  Current problems in the management of AIDS patients.

Authors:  N Clumeck; P Hermans; S De Wit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

5.  Acyclovir in recurrent herpes labialis.

Authors:  G Worrall
Journal:  BMJ       Date:  1996-01-06

Review 6.  Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s).

Authors:  M M Eibl; H M Wolf
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

7.  Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).

Authors:  J N Weber; S Thom; I Barrison; R Unwin; S Forster; D J Jeffries; A Boylston; A J Pinching
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

8.  Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions.

Authors:  G J Bubley; B Chapman; S K Chapman; C S Crumpacker; L E Schnipper
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 9.  Acyclovir prophylaxis for herpes simplex virus infection.

Authors:  D Gold; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

Review 10.  Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.

Authors:  Anne-Marie Fillet
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.